| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |